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Abstract
Background: ArtinM is a D-mannose-specific lectin from Artocarpus integrifolia seeds that induces neutrophil
migration and activation, degranulation of mast cells, acceleration of wound healing, induction of interleukin-12
production by macrophages and dendritic cells, and protective T helper 1 immune response against Leishmania
major, Leishmania amazonensis and Paracoccidioides brasiliensis infections. Considering the important biological
properties of ArtinM and its therapeutic applicability, this study was designed to produce high-level expression of
active recombinant ArtinM (rArtinM) in Escherichia coli system.
Results: The ArtinM coding region was inserted in pET29a(+) vector and expressed in E. coli BL21(DE3)-Codon
Plus-RP. The conditions for overexpression of soluble ArtinM were optimized testing different parameters:
temperatures (20, 25, 30 or 37°C) and shaking speeds (130, 200 or 220 rpm) during induction, concentrations of
the induction agent IPTG (0.01-4 mM) and periods of induction (1-19 h). BL21-CodonPlus(DE3)-RP cells induced
under the optimized conditions (incubation at 20°C, at a shaking speed of 130 rpm, induction with 0.4 mM
IPTG for 19 h) resulted in the accumulation of large amounts of soluble rArtinM. The culture provided 22.4 mg/
L of rArtinM, which activity was determined by its one-step purification through affinity chromatography on
immobilized D-mannose and glycoarray analysis. Gel filtration showed that rArtinM is monomeric, contrasting
with the tetrameric form of the plant native protein (jArtinM). The analysis of intact rArtinM by mass
spectrometry revealed a 16,099.5 Da molecular mass, and the peptide mass fingerprint and esi-cid-ms/ms of
amino acid sequences of peptides from a tryptic digest covered 41% of the total ArtinM amino acid sequence.
In addition, circular dichroism and fluorescence spectroscopy of rArtinM indicated that its global fold comprises
β-sheet structure.
Conclusions: Overall, the optimized process to express rArtinM in E. coli provided high amounts of soluble,
correctly folded and active recombinant protein, compatible with large scale production of the lectin.
Background
Lectins are proteins displaying at least one non-catalytic
domain, which specifically and reversibly binds to mono
or oligosaccharides [1]. Lectins are known as being an ex-
tremely useful tool for carbohydrate investigation on cell
surfaces, for glycoproteins isolation and characterization,
and for lymphocytes polyclonal activation. Numerous lec-
tins have been isolated from many organisms ranging
from viruses and bacteria to plants and animals, and they
are known to play a key role in a variety of biological pro-
cesses (reviewed in [2]). Plant lectins have many biomed-
ical applications (reviewed in [3]), including targeted drug
delivery (reviewed in [4]) and therapy against several kinds
of tumors and infections [5].
ArtinM is a D-mannose-binding lectin from seeds
of Artocarpus integrifolia that stimulates macrophages
and dendritic cells to produce IL-12 [6], an activity
triggered by the ArtinM interaction with the N-
glycans of TLR2 [7], and is able to induce Th1 biased
immune response. As a consequence, ArtinM admin-
istration to mice has been shown to confer resistance
to Leishmania [6,8], and Paracoccidioides brasiliensis
[7] infections. The lectin ArtinM is also capable of
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inducing neutrophil haptotactic migration mediated
by the simultaneous interaction of its carbohydrate recog-
nition domains (CRDs) with cell surface N-glycans (linked
to the CXCR2 molecule) [9] and extracellular matrix N-
glycans (linked to laminin) [10-12]. An amplification loop
for the in vivo ArtinM inflammatory activity is provided by
mast cell degranulation, which is most likely due to the lec-
tin interaction with glycans on FcRI [13]. In addition,
ArtinM is able to accelerate the process of wound healing
and epithelial tissue regeneration [14]. Therefore, ArtinM
has biomedical applications and is a potential pharmaceut-
ical agent. In this study we have aimed to produce high-
level expression of active soluble rArtinM in E. coli system.
Results and discussion
Optimization of soluble rArtinM expression in E. coli
The number of recombinant proteins used for thera-
peutic applications has increased dramatically [15]. In
this work, the ArtinM coding region was amplified by
PCR, using as template the cDNA clone pLL29
described previously [16]. The primers used were
designed to create an NdeI and a BamHI sites at the ini-
tiation and termination codons, respectively. The ampli-
fied product was about 460 bp (not shown), which is in
accordance with the length of the ArtinM coding region
(453 bp). This PCR fragment was digested with NdeI
and BamHI, and cloned into the NdeI and BamHI sites
of the pET29a(+) expression vector. The resulting con-
struction was confirmed by restriction analysis and se-
quencing (not shown) and named pET29-ArtinM.
Considering recombinant protein solubility as an indi-
cation of its correct folding and activity, our goal was to
establish the conditions to obtain high production of sol-
uble protein. Therefore, pET29-ArtinM was introduced
in E. coli BL21-CodonPlus(DE3)-RP, a strain that con-
tains the T7 expression system and extra copies of the
argU and proL tRNA genes. This strain was chosen be-
cause the ArtinM sequence analysis revealed several rare
codons (not shown). In our study, different conditions
were assayed to determine those able to provide optimal
overexpression of soluble ArtinM and four parameters
were tested: temperature and shaking speed during in-
duction, concentration of the induction agent (IPTG)
and period of induction (for details see Methods). These
four parameters were shown to be important in affecting
the amount and the solubility of rArtinM. Figure 1
shows the comparison between the results obtained in
two different conditions: one in which large amounts of
rArtinM was produced (incubation at 37°C, at a shaking
speed of 220 rpm, induction with 1.0 mM IPTG for
19 h), but in a insoluble form (Figure 1A), and the opti-
mized conditions (incubation at 20°C, at a shaking speed
of 130 rpm, induction with 0.4 mM IPTG for 19 h), in
which the highest amount of soluble rArtinM was pro-
duced (Figure 1B).
Taking advantage of the specificity of the carbohydrate
recognition property of ArtinM, the recombinant lectin
was purified from the E. coli lysate by affinity chroma-
tography on a D-mannose column, and was eluted with
0.1 M D-mannose in PBS, providing the profile showed
in Figure 2A. Such purification process by itself certifies
that the sugar binding activity of rArtinM was preserved.
Measurements by BCA assay (see Methods) revealed an
average yield of 22.4 mg rArtinM per liter of culture.
The rArtinM has been analyzed through TSK-G2000sw
gel-filtration column and the elution profile showed a
single peak of 16 kDa, consistent with the monomer mo-
lecular mass. Meanwhile, as expected, the jArtinM was
eluted in a volume compatible with the tetramer mo-
lecular mass (Figure 2B). The homogeneity of rArtinM
was confirmed by SDS-PAGE (Figure 2C). Taken to-
gether, these results show that the rArtinM produced in
E. coli is monomeric and capable to bind D-mannose.
Production of recombinant proteins in active and
highly purified form for biomedical research, biotechnol-
ogy, and pharmaceutical industry is a huge challenge.
The major and frequent difficulty in expressing a heter-
ologous protein in a bacterial system concerns the ten-
dency of the recombinant protein to become insoluble
[17]. Our data shows that in the optimized conditions
here defined (incubation at 20°C, at a shaking speed of
130 rpm, induction with 0.4 mM IPTG for 19 h), soluble
and active ArtinM is produced in large quantities in the
E. coli expression system.
rArtinM and jArtinM have similar primary structure
rArtinM was characterized by mass spectrometry and
N-terminal amino acid sequencing by automated Edman
degradation. Electrospray ionization mass spectrometry
(ESI-MS) has been regularly used to characterize recom-
binant proteins, since it is a rapid and precise method
for determining molecular mass of proteins and peptides
and can be used to validate protein sequences [18,19].
Therefore, a sample of purified rArtinM has been ana-
lyzed by ESI-triple quadrupole – mass spectrometer.
MaxEnt 1 algorithm was used for de-convolution of
multiple envelop ions which determined that rArtinM
has a molecular mass of 16,099.5 Da (Figure 3A). It is in
good agreement with the molecular mass determined for
jArtinM (masses of 16,101.5 and 16,114.5 Da for the two
major isoforms - data not shown) and the average mo-
lecular mass (16,124.11 Da) calculated from the amino
acid sequence [20]. Amino acid sequencing of peptides
derived from trypsin digestion of rArtinM, performed by
ESI-MS peptide mass fingerprinting (PMF) and collision
induced dissociation (CID-MS/MS) has covered 41% of
the total ArtinM amino acid sequence (Figure 3B,
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Table 1). The spectrum of C-terminal peptide
(Figure 3C) confirmed that rArtinM C-terminal se-
quence was equal to jArtinM (Table 1). N-terminal se-
quencing showed that the first 20 amino acids are in
accordance with the sequence of jArtinM, except for the
substitution of glutamine (Q) for arginine (R) at residue
3 (Figure 3D), which was confirmed by Edman degrad-
ation and mass spectrometry. This substitution was due
to an unintentional mutation introduced at the cloned
sequence, as verified by DNA sequencing. Mass spec-
trometry detected this new trypsin cleavage site
correspondent to a tryptic peptide at residues 4 to 27
(Table 1). N-terminal sequencing by Edman degradation
of rArtinM indicates that the recombinant protein was
not acetylated at the N-terminal, a modification that was
found in jArtinM [20]. The absence of N-acetylation
(−42 Da) at the N-terminal and replacement of Q for R
(+28 Da) account for a molecular mass of 16,113.5,
which is close to native isoforms (16,101.5 and
16,114.5 Da).
The absence of the initial methionine at the rArtinM
N-terminus, as in the mature jArtinM, was an interest-
ing and unexpected finding. Recombinant proteins pro-
duced in E. coli cytosol often possess the methionine,
corresponding to the translational initiation codon
(ATG), at the N-terminus [21]. In a significant fraction
of the E. coli endogenous cytosolic proteins, this N-
terminal methionine residue is excised by a methionyla-
minopeptidase (MAP) [22]. Biochemical and genetic
studies indicated that the major determinant for cleavage
by MAP is the amino acid occupying the N-terminal
penultimate position or, in other words, the second
amino acid [23,24]. According to the generally accepted
rules for MAP, one of the highest cleavage probabilities
is found when Ala is the second amino acid [24,25], as
in the ArtinM sequence. Therefore, it is reasonable to
propose that the N-terminal methionine of the rArtinM
was efficiently processed in E. coli BL21-CodonPlus
(DE3)-RP by endogenous MAPs.
The rArtinM has secondary and tertiary structures
equivalent to the jArtinM
Circular dichroism spectra (CD) and fluorescence spec-
troscopy of rArtinM and jArtinM were obtained in order
to evaluate the correct folding of the recombinant pro-
tein and determine some structural details (data not
shown). The analysis of secondary structure content
showed that rArtinM contained predominantly β-sheet
structure, as characterized by the positive ellipicity at
wavelength 195 nm and the negative ellipticity at
218 nm. Fluorescence measurements were performed in
order to verify the presence of tertiary structure, all
emission spectra were recorded from 300 – 450 nm with
excitation at 280 nm (data not shown). Thus, our CD
spectrum and the fluorescence analysis indicated that
rArtinM is correctly folded and has a defined conform-
ational structure suitable for comparative functional
studies.
Functional analysis of rArtinM using glycan array
The characterization of the specificities of glycan-
binding proteins is of primary importance for a recom-
binant lectin, and the glycan array has been an import-
ant tool for this investigation. The specificity of the
fluorescence-labelled lectins was evaluated by binding to
the 406 oligosaccharides present on the glycan array
Figure 1 Optimization of ArtinM expression. SDS-PAGE analysis of rArtinM expression after (A) 1 mM IPTG induction at 37 °C and 220 rpm
and (B) 0.4 mM IPTG induction at 20 °C and 130 rpm. Lanes 1A and 2A - soluble and insoluble bacterial lysate, respectively, after 4 hours of
induction; Lanes 3A and 4A - soluble and insoluble bacterial lysate, after 19 hours of induction. Lane 1B and 2B - insoluble and soluble bacterial
lysate, respectively, after 4 hours of induction; Lanes 3B and 4B - insoluble and soluble bacterial lysate, respectively, after 19 hours of induction.
Each lane contains 3 μg of total protein. MW molecular weight markers in kDa (LMW – Amersham).
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available at the Consortium for Functional Glycomics.
The glycan array profile for both native (jArtinM) and
recombinant ArtinM reveals that both lectin forms
recognized with high affinity the same subsets of
complex-type biantennary N-glycans containing Manα1-
3(Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ (data not
shown). This result is coherent with our recent observa-
tion that native and recombinant ArtinM interact with
equivalent kinetic rates and affinity equilibrium con-
stants to horseradish peroxidase glycoprotein [26], a N-
glycosylated protein that contains the trimannoside
Manα1-3[Manα1-6]Man, which is a known ligand for
jArtinM [27].
IL-12 inducing property of jArtinM is preserved in rArtinM
Functionally, we had previously demonstrated that jAr-
tinM induces IL-12 production by macrophage cell lines,
as well as peritoneal and spleen macrophages [6,7]. To
determine whether this property of jArtinM was pre-
served in rArtinM, we next verified the in vitro IL-12p70
production by spleen macrophages stimulated with 5 μg/
ml of rArtinM (Figure 4). We observed that the
rArtinM-stimulated macrophages released IL-12 in cul-
ture supernatants in concentrations that were similar to
the induced by the native protein, demonstrating that
the rArtinM produced in E. coli preserved this biological
activity exerted by the plant jArtinM. This fact is con-
ceptually acceptable, because IL-12 production is trig-
gered by ArtinM interaction with type 2 toll-like
receptor, whose usual agonists are low molecular mass
microbial components, unable to enclose more than one
site of interaction with the receptor. However, it is
expected that ArtinM activities that depend on receptor
cross-linking to be triggered, such as mast cell degranu-
lation, will not reproduced by the monomeric recombin-
ant lectin.
Conclusion
Considering the potential use of ArtinM as an immu-
notherapeutic molecule, this study was designed to pro-
duce high-level of soluble/active rArtinM in E. coli
system, for both research and pharmaceutical purposes.
Here we report a high-yield production of rArtinM lec-
tin using pET29a(+) and BL21-CodonPlus(DE3)-RP as
expression system, and its characterization by SDS–
PAGE, one-step purification through immobilized D-
mannose affinity chromatography, circular dichroism
(CD), fluorescence spectroscopy, glycoarray analysis and
IL-12 production. Several evidences indicate that the
final product, rArtinM, is correctly folded, biochemically
active and endowed of biological properties exerted by
the plant lectin ArtinM. Taken together, our data pro-
vides evidences that rArtinM will be a useful tool for fu-
ture biomedical studies and that E. coli expression
Figure 2 Purification of rArtinM. A) Elution profile of rArtinM on
D-mannose-Sepharose affinity column. The solid line corresponds to
protein elution as monitored by measuring absorption at 280 nm.
The arrow shows the D-mannose load. B) Size exclusion
chromatogram showing jArtinM (dashed line) and rArtinM (solid
line) elution. Positions of molecular weight standards are marked. C)
SDS-PAGE analysis of rArtinM. Lane 1 - purified jArtinM loaded as
control. Lane 2 - whole bacterial cell lysate. Lane 3 - rArtinM purified
by affinity column. Each lane contains 3 μg of protein.
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Figure 3 Mass spectrometric analysis of rArtinM. A) Molecular mass of rArtinM (of 16099.5 Da) was determined by ESI-triple quadrupole mass
spectrometer. The insertion in figure shows protonated envelop of ions which were de-convoluted to Mw using MaxEnt 1 algorithm. B) Mass
fingerprint obtained from tryptic digested rArtinM in solution was analyzed by ESI-triple quadrupole scanning from 400 to 1500 amu in the
positive ion mode for detection of protonated peptides. C) Each tryptic peptide was subjected to collision-induced dissociation to produce a
fragment ion pattern and the amino acid sequence was deduced from fragment ions type b and y, as an example, spectrum of tryptic peptide
m/z 713.7 [M+ 2 H+] which corresponds to the C-terminal peptide. Other tryptic peptides are listed in Table 1. D) Amino acid sequence of
rArtinM determined by Edman degradation (N-terminal, residues 1–20) and tryptic peptides by mass spectrometry (bold).
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system is appropriate to produce large quantities of
functional ArtinM for industrial purposes.
Methods
Cloning the ArtinM coding region in a E. coli expression
vector
The coding region of the ArtinM lectin was amplified by
PCR using as template the cDNA clone pLL29 previ-
ously described [16]. The primers (forward -5’gaaggtgaat
catATGgcgagccag3’ and reverse - 5’ggacatattggatccCT
Aaagtgcc3’) used for cloning the ArtinM coding region
introduced the restriction site NdeI (underlined) at the
initiation codon (capital letters) and the BamHI site
(underlined) just after the stop codon (capital letters).
These primers were used for amplification with the Tri-
pleMaster polymerase (Eppendorf, Hamburg, Germany),
under the following PCR conditions: 3 min at 94°C fol-
lowed by 35 cycles of 1 min at 94°C, 45 s at 55°C, and
1 min at 72°C; the final extension was for 7 min at 72°C.
The PCR product was digested with the NdeI and
BamHI restriction enzymes, separated on a 1% agarose
gel and extracted from the gel using a phenol/chloro-
form protocol. The pET-29a(+) vector was digested with
the same two enzymes and purified from a 1% agarose
gel. The digested PCR fragment of ArtinM (453 bp) was
ligated into the linearized vector pET-29a(+). The
resulting vector, named pET29-ArtinM, was con-
firmed by restriction analyses and sequencing and
introduced in E. coli BL21-CodonPlus(DE3)-RP cells
by electroporation.
Optimization of ArtinM expression
E. coli BL21-CodonPlus(DE3)-RP transformants were
inoculated in 5 mL of Luria–Bertani (LB) medium sup-
plemented with kanamycin 50 μg/mL and cultivated
overnight at 37°C. This pre-culture was used to inoculate
(1:100) a 100 mL LB medium containing kanamycin,
which was cultivated at 37°C until reaching a DO600nm
of 0.5-0.6. Then, an aliquot of 10 mL was collected (T0)
and IPTG was added. To optimize ArtinM expression,
IPTG was tested at different final concentrations (0.01,
0.05, 0.1, 0.2, 0.4, 0.8, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0 mM).
After the addition of IPTG, each culture was incubated
at different temperatures (20, 25, 30 or 37°C), under dif-
ferent shaking speeds (130, 200 or 220 rpm), for differ-
ent incubation periods (1, 2, 4, 8, 16 and 19 hours).
Aliquots (10 mL) were collected at these specific time
points to evaluated rArtinM expression. Cells were pel-
leted by centrifugation at 5,000 × g at 4°C for 5 min, the
culture medium was discarded and cells ressuspended in
lysis buffer (10 mM Tris–HCl, 300 mM NaCl, 1 mM
EDTA, 5 mM DTT, 100 μg/mL lysozyme, 0.5% (v/v) gly-
cerol and protease inhibitors). The homogenates were
sonicated 4 times for 30 seconds, with 30 seconds inter-
val between each sonication and then, centrifuged to
separate supernatant and pellet. These samples were
quantified and analyzed by SDS-PAGE.
For the additional analyses of rArtinM, a pre-culture
aliquot of 1.5 mL was used to inoculate 150 mL LB
medium. Cells were cultivated at 37°C to an OD600nm of
about 0.6. Then temperature was decreased to 20°C and
the expression of ArtinM was induced by the addition of
0.4 mM IPTG (Appli-Chem GmbH, Darmstadt, Ger-
many) and cells were allowed to grow for another 19 h
at 130 rpm. Cells were harvested by centrifugation at
8,000 × g at 4°C for 20 min. The cell pellets were used
immediately for protein purification or frozen in liquid
nitrogen and stored at −70°C.
Table 1 Tryptic peptide mass mapping obtained from rArtinM
m/z Mr Residues Sequence
440.9 [M+ 2 H+] 879.47 29-35 (R)QIELSYK(E)
547.4 [M+ 3 H+] 1,637.86 135-150 (K)GRTGDLLDAIGVHMAL(−)
713.7 [M+ 2 H+] 1,424.73 137-150 (R)TGDLLDAIGVHMAL(−)
1,114.9 [M+ 2 H+] 2,226.08 36-56 (K)EAIGSFSVIYDLNGEPFSGPK(H)
1,211.6 [M+ 2 H+] 2,419.12 4-27 (R)TITVGPWGGPGGNGWDDGSYTGIR(Q)
1,450.5 [M+ 2 H+] 2,898.45 72-98 (R)FPDEFLESVSGYTAPFSALATPTPVVR(S)
Figure 4 IL-12 production induced by rArtinM. Peritoneal
macrophages were cultured for 48 hours in the presence or absence
of zymosan (10 μg/ml), jArtinM (5 μg/ml), rArtinM (5 μg/ml). The
amount of IL-12p40 in the supernatant was determined by capture
ELISA.
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ArtinM Affinity Purification
jArtinM, extracted from Artocarpus integrifolia seeds,
was purified as previously described [28]. E. coli BL21-
CodonPlus(DE3)-RP was used to express rArtinM as
described above and soluble proteins were obtained
through bacterial sonication and centrifugation at
25,000 × g for 15 min. The supernatants were submitted
to affinity-chromatography on a D-mannose column,
previously equilibrated at 4°C with PBS containing
0.5 M NaCl. After washing with equilibrating buffer, the
adsorbed material was eluted with 0.1 M D-mannose in
equilibrating buffer. The obtained preparation was ultra-
diafiltered against PBS, using YM10 membrane (Amicon
Division, W.R. Grace, Beverly, MA). ArtinM prepara-
tions contained less than 0.05 ng/ml of bacterial endo-
toxin, as determined by the Limulus amoebocyte lysate
assay (Sigma Chemical Co., St. Louis, MO).
Protein analyses
Protein quantification was performed through the
bicinchoninic acid (BCA) assay (Sigma Chemical Co., St.
Louis, MO), using BSA as standard [29]. Protein electro-
phoresis was carried out by conventional SDS–PAGE
and the gels have been stained with Coomassie blue R-
250 (Sigma Chemical Co., St. Louis, MO).
Analytical size exclusion chromatography
Analytical size exclusion chromatography was performed
on a TSK-G2000sw (30 cm×7.8 mm, Tosoh) equili-
brated in 50 mM KH2PO4, 300 mM NaCl, pH 7.4. The
column was calibrated with bovine thyroglobulin
(669 kDa), immunoglobulin G (157 kDa), ovalbumin
(45 kDa), and myoglobin (17 kDa) (Sigma).
Mass spectrometric analysis of ArtinM
Native and recombinant Artin M were desalted in
POROS R2 (Perseptive Biosystem, Foster City, CA) and
about 2.5 μg of each sample was directly infused by syr-
inge pump (Harvard Apparatus, Holliston, MA) into a
triple-quadrupole mass spectrometer (Quattro II, Micro-
mass, Manchester, UK) equipped with an electrospray
ion source. Fifteen scans were collected between 400
and 2000 amu, and the molecular weight was deter-
mined after de-convolution of multi-charged ions
spectrum by MaxEnt1 algorithm (MaxLynx software
v3.3, Micromass, Manchester, UK).
Peptide mass fingerprint of rArtinM
An aliquot of 2.5 μg of rArtin M was heated denatured
and subjected to enzymatic digestion with 0.5 μg of
modified trypsin (Promega, Madison, WI, USA) for 24 h
at 37°C. The enzyme reaction was stopped with 5 μL of
neat formic acid. The tryptic peptides were desalted in
POROS R2 (Perseptive Biosystem) previously activated
with methanol, equilibrated in 0.2% formic acid and the
peptides were eluted in 60% methanol, 5% formic acid.
The MS analysis of tryptic peptides was carried out by
ESI-triple quadrupole MS (Quattro II, Micromass, Man-
chester, UK) at the mass range of 400–1500 u.m.a. and
the peptide ions were selected to collision induced dis-
sociation (CID-MS/MS) to produce fragments pattern
mainly type b and y which were used for deduction of
amino acid sequences.
Spectroscopic characterization of recombinant ArtinM
Far UV circular dichroism spectra were performed using
a Jasco J-810 spectropolarimeter in the wavelength range
of 190–280 nm. Measurements were made on the puri-
fied ArtinM lectin (native and recombinant) at a concen-
tration of 0.5 mg/mL, using quartz cuvettes of 0.l mm
path length. Spectra were typically recorded as the aver-
age of 6 scans. CD spectra were obtained in milli-
degrees and converted to molar ellipticity. Intrinsic tryp-
tophan fluorescence emission (IFTE) spectra were mea-
sured using a SLM-AMINCO 8100c (Spectronic
Instruments) between 300 and 450 nm using an excita-
tion wavelength of 280 nm at protein concentration of
5 mg/ml. The excitation and emission slit widths fixed
at 4 nm and the photomultiplier tube voltage was 600 V.
In all spectroscopic measurements the buffer was saline
(150 mM NaCl).
Glycoarray analysis
A high-throughput screening for identify lectin-ligand
interactions was performed by the standard procedure of
Core H of the Consortium for Functional Glycomics
[30]. Briefly, synthetic glycans functionalized with a spa-
cer and terminating NH2 groups were spotted onto
NHS-activated microscope slides (Slide H). Lectins at a
concentration of 20–200 μg/mL in a buffer of PBS con-
taining 0.005%–0.5% Tween-20 were incubated on the
arrays for 30–60 min. The lectins were tagged with a
Fluorescein isothiocyanate (FITC, Molecular Probes).
The arrays were washed and immediately scanned for
fluorescence using a microarray scanner. Image analysis
software was used to quantify the fluorescence inten-
sities at each glycan spot. The data from six replicate
spots were averaged to achieve a final value.
Spleen cell cultures
Suspensions of spleen cells from the C57BL/6 were
washed in RPMI-I (RPMI 1640 - Flow Laboratories, Inc.,
McLean, VA) and treated with lyses buffer (9 parts of
0.16 M ammonium chloride and 1 part of 0.17 M Tris–
HCl, pH 7.5) for 4 min. The erythrocyte-free cells were
then washed three times in RPMI-I, resuspended in
RPMI-C (containing 2 mM L-glutamine, 50 μM 2-
mercaptoethanol, 100 U/ml penicillin, 100 μg/ml
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streptomycin [Sigma-Aldrich] and 5% heat-inactivated
fetal calf serum [Hyclone, Logan, UT]), and dispensed in
24-well cell culture plates (1 × 107 cells/well). After 2–
4 h incubation at 37°C, the non-adherent cells were
removed by exhaustive washing with RPMI-I, and the
adherent cells were incubated with jArtinM (5 μg/ml),
rArtinM (5 μg/ml), and zymosan (10 μg/ml) – which
had been previously boiled for 30 min and washed twice
with PBS. After 48 h incubation, the supernatants were
harvested by centrifugation and stored at −20°C until
IL-12p40 ELISA was performed.
IL-12p40 ELISA
The levels of IL-12p40 in the macrophage supernatants
were measured by capture enzyme-linked immunosorb-
ent assay (ELISA) with antibody pairs purchased from
Pharmingen (Pharmingen, San Diego, USA). The ELISA
procedure was performed according to the manufac-
turer’s protocol. The IL-12p40 concentration was deter-
mined with reference to a standard curve for murine
recombinant IL-12.
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